Gait Characteristics Following a Fall

This study is currently recruiting participants.

Verified June 2012 by Hadassah Medical Organization

Sponsor:

Information provided by (Responsible Party):

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT01631604

First received: June 28, 2012

Last updated: July 5, 2012

Last verified: June 2012

History of Changes

Tracking Information

First Received Date ^ICMJE

June 28, 2012

Last Updated Date

July 5, 2012

Start Date ^ICMJE

June 2012

Primary Completion Date

June 2014 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Gait kinematics

Joint angles, velocities and accelerations

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT01631604 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Muscle activation patterns

Dynamic EMG of various muscles.

Original Secondary Outcome Measures ^ICMJE

Same as current

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Gait Characteristics Following a Fall

Official Title ^ICMJE

Quantification of Gait Parameters and Muscle Activation Patterns Following a Fall

Brief Summary

The purpose of this study is to quantify the safety degree of the patient's gait, to detect the reason for the fall and quantify the biomechanical parameters related to fall. This study also aims to evaluate the effect of different rehabilitation treatments and their effect on the risk of falling.

Detailed Description

In this study, patients suffering from motor disabilities as a result of orthopedic or neurologic impairments will be tested at the gait and motion laboratory. Each patient will be secured with a ceiling-mounted safety harness and will walk on the path wearing passive light-reflecting markers and surface electrodes. High-speed cameras will record the subject's movements and the markers will be tracked to produce data of joint angles, velocities and accelerations. Dynamic EMG will be recorded from various muscles.

During the examination, the gait of the subjects will be disturb by either (i) a visual or sound signal that requires the subject to stop immediately, or (ii) walking different terrains, or (iii) tying a string to the foot and pulling it shortly to induce a trip.

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Endpoint Classification: Safety/Efficacy Study
Intervention Model: Factorial Assignment
Primary Purpose: Treatment

Condition ^ICMJE

Motor Impairments
Orthopaedic Injuries
Neurological Conditions

Intervention ^ICMJE

Device: Walking aids and devices
Walking aids, e.g. braces, canes,orthoses, prosthetics, etc.
Drug: Muscle/nerve injection
Injection to muscle or nerve
Other Names:
- Botulinum toxin
- Marcaine
Procedure: Corrective surgery
correction of spinal and bony deformities, muscle transfer, tendon elongation etc.
Other Names:
- Knee arthroscopy, meniscectomy and chondroplasty
- Anterior cruciate ligament reconstruction
- Knee replacement
- Repair of femoral neck fracture
- Repair of trochanteric fracture
- Debridement of skin/muscle/bone/fracture
- Knee arthroscopy repair of both menisci
- Hip replacement
- Repair of ankle fracture (bimalleolar type)
- Lumbar spinal fusion
- Low back intervertebral disc surgery
- Repair of femoral shaft fracture
Other: Physical therapy treatment

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

June 2014

Primary Completion Date

June 2014 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Individuals suffering from gait impairment following injury to the central or peripheral nervous system, as well as following orthopedic injuries. The subjects will be able to understand and independently sign a consent form.

Exclusion Criteria:

Subjects who are unable to understand and independently sign a consent form
Subjects who are wheelchair bound.
Pregnant women.

Gender

Both

Ages

5 Years and older

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact: Sigal Portnoy, Ph.D.

97225844492

sigalp@hadassah.org.il

Location Countries ^ICMJE

Israel

Administrative Information

NCT Number ^ICMJE

NCT01631604

Other Study ID Numbers ^ICMJE

Fall-HMO-CTIL

Has Data Monitoring Committee

Not Provided

Responsible Party

Hadassah Medical Organization

Study Sponsor ^ICMJE

Hadassah Medical Organization

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Not Provided

Information Provided By

Hadassah Medical Organization

Verification Date

June 2012

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top